Breakthrough Medication DR10624 Shows Promise in Treating Hypertriglyceridemia
Update: 2025-11-08
Description
DR10624, a new medication, demonstrated significant reductions in triglyceride levels and liver fat in patients with severe hypertriglyceridemia, as presented at the American Heart Association's Scientific Sessions 2025. The results suggest it could be a game-changer in treatment options, although further research is needed to confirm its safety and efficacy. Additionally, the Fifth Annual Sickle Cell Caregiver Summit, focusing on mental wellness and advocacy, will be held virtually in November 2025, providing education and empowerment for caregivers, patients, and advocates worldwide.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
